BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29110361)

  • 1. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Cornet E
    Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
    Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
    Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and Treatment of Hairy Cell Leukemia.
    Paillassa J; Troussard X
    Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoconjugates and new molecular targets in hairy cell leukemia.
    Kreitman RJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():660-6. PubMed ID: 23233649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
    Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
    J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
    Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoconjugates in the management of hairy cell leukemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hairy cell leukemia].
    Maitre E; Wiber M; Cornet E; Troussard X
    Presse Med; 2019; 48(7-8 Pt 1):842-849. PubMed ID: 31447330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
    Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
    Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review.
    Ito M; Harada T; Lang L; Saga T; Kanagawa M; Matsuda R; Yashiro S; Kano S; Sasaki Y; Nakamine H
    Int J Surg Pathol; 2022 Oct; 30(7):828-838. PubMed ID: 35234079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow and splenic histology in hairy cell leukaemia.
    Wotherspoon A; Attygalle A; Mendes LS
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
    Maitre E; Paillassa J; Troussard X
    Front Oncol; 2022; 12():1068981. PubMed ID: 36620555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.